Category: Talks and Publications

Journal of Commercial Biotechnology October 2012 Issue Now Available

Journal of Commercial Biotechnology Vol 18, Issue 4 (2012) The Birth of a Discipline Arlen Meyers Bioentrepreneurship is a new academic discipline Full details at theJournal of Commercial Biotechnology Not fully harmonized: Differences in biotechnology patenting between Europe and the United States Brian R Dorn, Zoë Birtle There has been a trend of worldwide harmonization […]

Revolutions: Paving the way for the Bioeconomy

Logos Press has just published a new book by Randall Mayes. Revolutions: Paving the Way for the Bioeconomy is an in-depth look at the increasing impact of biology primarily due to the potential of genomics. The book focuses on four revolutions: Industrial Revolutions Genomics researchers hope to launch personalized medicine and cure diseases by identifying drug […]

Apple vs. Microsoft model for diagnostic testing?

Human Genetic Signatures has elected to make their recent Journal of Commercial Biotechnology paper open access through the JCB’s Open Access Option. By electing for open access, the paper is now free to read without subscription. For more on their assessment of the Microsoft vs. Apple ‘black-box’ model for diagnostic testing, see their paper: What […]

Journal of Commercial Biotechnology July 2012 issue now available

Journal of Commercial Biotechnology Vol 18, Issue 3 (2012) Could personalized medicine be the driver for widespread price controls? Yali Friedman Everyone should agree that the benefits of personalized medicine — prescription of drugs most likely to benefit and least likely to harm individual or groups of patients — are are positive. However, one must […]

Pharmaceutical globalization: Where are drugs invented?

I’m back from the Filling the Pipeline conference in Boston, where I presented a talk on pharmaceutical globalization. Maintaining control of pharmaceutical drug innovation is key for national security, public health, and economic development. We know that much of late-stage development has gone overseas, but the question remains: Where are drugs invented? Using the DrugPatentWatch […]

Third Annual Scientific American Worldview: Measuring Global Biotechnology

The third issue of Scientic American’s Worldview is now available at In this latest issue I continue my comparative assessment of the biotechnology innovation environment in different countries. I also include additional highlights: Which country is home to the most drug inventors? Which country has the greatest biotechnology patenting intensity? Which country has the […]

Biotechnology Book Booksignings at BIO 2011

The following Logos Press authors will be signing books at the BIO 2011 Convention in Washington DC Monday June 27th 3:00-4:30pm Mark Ahn, Michael Alvarez, Anne York Building the Case for Biotechnology: Management Case Studies in Science, Laws, Regulations, Politics, and Business Tuesday June 28th 3pm-4:30pm Yali Friedman Building Biotechnology: The definitive biotechnology industry primer […]

Individual Biotechnology Management Cases now Available

I am pleased to announce the availability of  individual cases from Building the Case for Biotechnology Management Case Studies in Science, Laws, Regulations, Politics, and Business in digital and printed formats. The casebook, which was recently reviewed in Nature Biotechnology, features 22 case studies in science; law, regulation, politics; and business, and a foreword by […]

Going Global: Partnering and Investing in International Life Sciences

I will be presenting in an upcoming webinar: Going Global Partnering and Investing in International Life Sciences   Today, successful life sciences companies are feverishly evaluating international partnerships in search of places that are rapidly expanding. Some make the costly mistake of only using market size as the deciding factor, which is often misleading. Success […]

%d bloggers like this: